Publications by authors named "Matthew Byott"

Claim this Profile
A
Addressing the Risk of HBV Transmission in Serodifferent Partners.
Athanasios Mamarelis, Matthew Byott, Stuart Flanagan, Indrajit Gosh, Eleni Nastouli

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice.
Flora Olcott, Philip D Oddie, Maeve J Barlow, Athanasios Mamarelis, Matthew Byott

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance.
Johannes C Botha, Matthew Byott, Moira J Spyer, Paul R Grant, Kathleen Gärtner

Viruses· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study.
Oliver Stirrup, James Blackstone, Fiona Mapp, Alyson MacNeil, Monica Panca, Matthew Byott

Elife· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation of a Rapid Variant-Proof RT-RPA Assay for the Detection of SARS-CoV-2.
Dounia Cherkaoui, Judith Heaney, Da Huang, Matthew Byott, Benjamin S Miller

Diagnostics (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.
Florencia A T Boshier, Cristina Venturini, Oliver Stirrup, José Afonso Guerra-Assunção, Adela Alcolea-Medina, Matthew Byott

J Infect· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.
Dan Frampton, Tommy Rampling, Aidan Cross, Heather Bailey, Judith Heaney, Matthew Byott

Lancet Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.
Nikhil Faulkner, Kevin W Ng, Mary Y Wu, Ruth Harvey, Marios Margaritis, Matthew Byott

Elife· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study.
Ankur Gupta-Wright, Katherine Fielding, Joep J van Oosterhout, Melanie Alufandika, Daniel J Grint, Matthew Byott

Lancet HIV· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories.
Sigi Van den Wijngaert, Nathalie Bossuyt, Bridget Ferns, Laurent Busson, Gabriela Serrano, Matthew Byott

Front Public Health· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neanderthal and Denisovan retroviruses in modern humans.
Emanuele Marchi, Alex Kanapin, Matthew Byott, Gkikas Magiorkinis, Robert Belshaw

Curr Biol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis